Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

[1]  I. Zlobec,et al.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget , 2010, Oncotarget.

[2]  L. Mazzucchelli,et al.  Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. , 2010, World journal of gastroenterology.

[3]  L. Påhlman,et al.  Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  C. Compton.  Prognostic Factors in Cancer , 2009 .

[5]  L. Terracciano,et al.  CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer , 2009, British Journal of Cancer.

[6]  L. Terracciano,et al.  Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups , 2009, Cancer.

[7]  N. Moriyama,et al.  Accuracy of High-Resolution Magnetic Resonance Imaging in Preoperative Staging of Rectal Cancer , 2009, Annals of Surgical Oncology.

[8]  O. Zmora,et al.  A New Rectal Ultrasonographic Method for the Staging of Rectal Cancer , 2009, Diseases of the colon and rectum.

[9]  J. O’Sullivan,et al.  Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer , 2009, The American journal of surgical pathology.

[10]  P. Quirke,et al.  Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. , 2008, The Lancet. Oncology.

[11]  C. Compton.  Optimal Pathologic Staging: Defining Stage II Disease , 2007, Clinical Cancer Research.

[12]  J. Tepper,et al.  Current Options for the Management of Rectal Cancer , 2007, Current treatment options in oncology.

[13]  L. Terracciano,et al.  Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer , 2007, The Journal of pathology.

[14]  B. Rubino,et al.  The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.

[15]  R. Heald,et al.  Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[16]  S. Badger,et al.  Preoperative staging of rectal carcinoma by endorectal ultrasound: is there a learning curve? , 2007, International Journal of Colorectal Disease.

[17]  F. Prall.  Tumour budding in colorectal carcinoma , 2007, Histopathology.

[18]  M. Barten,et al.  Tumour budding as prognostic factor in stage I/II colorectal carcinoma , 2005, Histopathology.

[19]  K. Guzińska-ustyMowiCz.  The role of tumour budding at the front of invasion and recurrence of rectal carcinoma. , 2005, Anticancer research.

[20]  Hidetaka Mochizuki,et al.  Risk factors for an adverse outcome in early invasive colorectal carcinoma. , 2004, Gastroenterology.

[21]  R. Newcombe,et al.  Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? , 2004, British Journal of Cancer.

[22]  H. Ueno,et al.  Predictors of extrahepatic recurrence after resection of colorectal liver metastases , 2004, The British journal of surgery.

[23]  B. Leggett,et al.  APC mutation and tumour budding in colorectal cancer , 2003, Journal of clinical pathology.

[24]  K. Hase,et al.  Prognostic value of tumor “budding” in patients with colorectal cancer , 1993, Diseases of the colon and rectum.

[25]  M. Morimatsu,et al.  An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer , 1989, Cancer.

[26]  J. Jass.  Lymphocytic infiltration and survival in rectal cancer. , 1986, Journal of clinical pathology.

[27]  J. Cuzick,et al.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases , 1986, Histopathology.